The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis
Identifieur interne : 000899 ( Main/Corpus ); précédent : 000898; suivant : 000900The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis
Auteurs : Li ChaiSource :
- Transfusion [ 0041-1132 ] ; 2011-11.
Abstract
The National Blood Foundation (NBF) support was critical in the author's research career development. The NBF support came in the form of a start‐up seed grant that she got from the American Association of Blood Banks, an organization that advances the practice and standards of transfusion medicine and cellular therapies and an organization in which she is a proud member. The NBF grant enabled her to keep up with her transfusion medicine practice while pursuing her passion to be a physician scientist. During its funding period, she was able to obtain critical preliminary bench data and to secure several National Institutes of Health grants with over a million dollars direct cost. In addition, the knowledge gained from the NBF‐supported projects is currently being translated into medical practice in her lab by testing on cord blood expansion. She is looking forward to spending the upcoming years of her professional career bridging bedside observations on transfusion medicine with bench experiences and then utilizing that bench‐derived knowledge in the practice of transfusion medicine.
Url:
DOI: 10.1111/j.1537-2995.2011.03371.x
Links to Exploration step
ISTEX:ECEA792C6DB2ECF82EF69BEE4DD911D30F6B7EB0Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis</title><author><name sortKey="Chai, Li" sort="Chai, Li" uniqKey="Chai L" first="Li" last="Chai">Li Chai</name><affiliation><mods:affiliation>From the Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:ECEA792C6DB2ECF82EF69BEE4DD911D30F6B7EB0</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1111/j.1537-2995.2011.03371.x</idno><idno type="url">https://api.istex.fr/document/ECEA792C6DB2ECF82EF69BEE4DD911D30F6B7EB0/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000899</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis</title><author><name sortKey="Chai, Li" sort="Chai, Li" uniqKey="Chai L" first="Li" last="Chai">Li Chai</name><affiliation><mods:affiliation>From the Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Transfusion</title><idno type="ISSN">0041-1132</idno><idno type="eISSN">1537-2995</idno><imprint><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><date type="published" when="2011-11">2011-11</date><biblScope unit="volume">51</biblScope><biblScope unit="supplement">s4</biblScope><biblScope unit="page" from="87S">87S</biblScope><biblScope unit="page" to="93S">93S</biblScope></imprint><idno type="ISSN">0041-1132</idno></series><idno type="istex">ECEA792C6DB2ECF82EF69BEE4DD911D30F6B7EB0</idno><idno type="DOI">10.1111/j.1537-2995.2011.03371.x</idno><idno type="ArticleID">TRF3371</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0041-1132</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The National Blood Foundation (NBF) support was critical in the author's research career development. The NBF support came in the form of a start‐up seed grant that she got from the American Association of Blood Banks, an organization that advances the practice and standards of transfusion medicine and cellular therapies and an organization in which she is a proud member. The NBF grant enabled her to keep up with her transfusion medicine practice while pursuing her passion to be a physician scientist. During its funding period, she was able to obtain critical preliminary bench data and to secure several National Institutes of Health grants with over a million dollars direct cost. In addition, the knowledge gained from the NBF‐supported projects is currently being translated into medical practice in her lab by testing on cord blood expansion. She is looking forward to spending the upcoming years of her professional career bridging bedside observations on transfusion medicine with bench experiences and then utilizing that bench‐derived knowledge in the practice of transfusion medicine.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Li Chai</name><affiliations><json:string>From the Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</json:string></affiliations></json:item></author><language><json:string>eng</json:string></language><abstract>The National Blood Foundation (NBF) support was critical in the author's research career development. The NBF support came in the form of a start‐up seed grant that she got from the American Association of Blood Banks, an organization that advances the practice and standards of transfusion medicine and cellular therapies and an organization in which she is a proud member. The NBF grant enabled her to keep up with her transfusion medicine practice while pursuing her passion to be a physician scientist. During its funding period, she was able to obtain critical preliminary bench data and to secure several National Institutes of Health grants with over a million dollars direct cost. In addition, the knowledge gained from the NBF‐supported projects is currently being translated into medical practice in her lab by testing on cord blood expansion. She is looking forward to spending the upcoming years of her professional career bridging bedside observations on transfusion medicine with bench experiences and then utilizing that bench‐derived knowledge in the practice of transfusion medicine.</abstract><qualityIndicators><score>6.459</score><pdfVersion>1.4</pdfVersion><pdfPageSize>594 x 783 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>0</keywordCount><abstractCharCount>1100</abstractCharCount><pdfWordCount>3919</pdfWordCount><pdfCharCount>24638</pdfCharCount><pdfPageCount>7</pdfPageCount><abstractWordCount>170</abstractWordCount></qualityIndicators><title>The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis</title><genre><json:string>article</json:string></genre><host><volume>51</volume><pages><total>7</total><last>93S</last><first>87S</first></pages><issn><json:string>0041-1132</json:string></issn><genre></genre><language><json:string>unknown</json:string></language><eissn><json:string>1537-2995</json:string></eissn><title>Transfusion</title><doi><json:string>10.1111/(ISSN)1537-2995</json:string></doi></host><publicationDate>2011</publicationDate><copyrightDate>2011</copyrightDate><doi><json:string>10.1111/j.1537-2995.2011.03371.x</json:string></doi><id>ECEA792C6DB2ECF82EF69BEE4DD911D30F6B7EB0</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/ECEA792C6DB2ECF82EF69BEE4DD911D30F6B7EB0/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/ECEA792C6DB2ECF82EF69BEE4DD911D30F6B7EB0/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/ECEA792C6DB2ECF82EF69BEE4DD911D30F6B7EB0/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><availability><p>WILEY</p></availability><date>2011</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis</title><author><persName><forename type="first">Li</forename><surname>Chai</surname></persName><note type="correspondence"><p>Correspondence: L. Chai, Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115; e‐mail: .</p></note><affiliation>From the Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</affiliation></author></analytic><monogr><title level="j">Transfusion</title><idno type="pISSN">0041-1132</idno><idno type="eISSN">1537-2995</idno><idno type="DOI">10.1111/(ISSN)1537-2995</idno><imprint><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><date type="published" when="2011-11"></date><biblScope unit="volume">51</biblScope><biblScope unit="supplement">s4</biblScope><biblScope unit="page" from="87S">87S</biblScope><biblScope unit="page" to="93S">93S</biblScope></imprint></monogr><idno type="istex">ECEA792C6DB2ECF82EF69BEE4DD911D30F6B7EB0</idno><idno type="DOI">10.1111/j.1537-2995.2011.03371.x</idno><idno type="ArticleID">TRF3371</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2011</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>The National Blood Foundation (NBF) support was critical in the author's research career development. The NBF support came in the form of a start‐up seed grant that she got from the American Association of Blood Banks, an organization that advances the practice and standards of transfusion medicine and cellular therapies and an organization in which she is a proud member. The NBF grant enabled her to keep up with her transfusion medicine practice while pursuing her passion to be a physician scientist. During its funding period, she was able to obtain critical preliminary bench data and to secure several National Institutes of Health grants with over a million dollars direct cost. In addition, the knowledge gained from the NBF‐supported projects is currently being translated into medical practice in her lab by testing on cord blood expansion. She is looking forward to spending the upcoming years of her professional career bridging bedside observations on transfusion medicine with bench experiences and then utilizing that bench‐derived knowledge in the practice of transfusion medicine.</p></abstract></profileDesc><revisionDesc><change when="2011-11">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/ECEA792C6DB2ECF82EF69BEE4DD911D30F6B7EB0/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Inc</publisherName><publisherLoc>Malden, USA</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1537-2995</doi><issn type="print">0041-1132</issn><issn type="electronic">1537-2995</issn><idGroup><id type="product" value="TRF"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="TRANSFUSION">Transfusion</title></titleGroup></publicationMeta><publicationMeta level="part" position="11004"><doi origin="wiley">10.1111/trf.2011.51.issue-s4</doi><titleGroup><title type="specialIssueTitle">The National Blood Foundation: 10 Years of Supporting Pioneering Cellular Therapy Research</title></titleGroup><numberingGroup><numbering type="journalVolume" number="51">51</numbering><numbering type="supplement">s4</numbering></numberingGroup><coverDate startDate="2011-11">November 2011</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="5" status="forIssue"><doi origin="wiley">10.1111/j.1537-2995.2011.03371.x</doi><idGroup><id type="unit" value="TRF3371"></id></idGroup><countGroup><count type="pageTotal" number="7"></count></countGroup><titleGroup><title type="tocHeading1">SUPPLEMENT ARTICLES</title></titleGroup><copyright>© 2011 American Association of Blood Banks</copyright><eventGroup><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.10 mode:FullText" date="2011-11-10"></event><event type="firstOnline" date="2011-11-10"></event><event type="publishedOnlineFinalForm" date="2011-11-10"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-10"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-04"></event></eventGroup><numberingGroup><numbering type="pageFirst">87S</numbering><numbering type="pageLast">93S</numbering></numberingGroup><correspondenceTo>L. Chai, Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115; e‐mail: <email>lchai@partners.org</email>.</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:TRF.TRF3371.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Received for publication April 16, 2011; revision received June 17, 2011, and accepted June 30, 2011.</unparsedEditorialHistory><countGroup><count type="figureTotal" number="5"></count><count type="tableTotal" number="1"></count><count type="formulaTotal" number="0"></count><count type="referenceTotal" number="38"></count><count type="wordTotal" number="4393"></count><count type="linksPubMed" number="0"></count><count type="linksCrossRef" number="0"></count></countGroup><titleGroup><title type="main">The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis</title><title type="shortAuthors">CHAI</title><title type="short">TRANSCRIPTION FACTORS IN HEMATOPOIESIS</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1" corresponding="yes"><personName><givenNames>Li</givenNames><familyName>Chai</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="US"><unparsedAffiliation>From the Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</unparsedAffiliation></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:lang="en"><p>The National Blood Foundation (NBF) support was critical in the author's research career development. The NBF support came in the form of a start‐up seed grant that she got from the American Association of Blood Banks, an organization that advances the practice and standards of transfusion medicine and cellular therapies and an organization in which she is a proud member. The NBF grant enabled her to keep up with her transfusion medicine practice while pursuing her passion to be a physician scientist. During its funding period, she was able to obtain critical preliminary bench data and to secure several National Institutes of Health grants with over a million dollars direct cost. In addition, the knowledge gained from the NBF‐supported projects is currently being translated into medical practice in her lab by testing on cord blood expansion. She is looking forward to spending the upcoming years of her professional career bridging bedside observations on transfusion medicine with bench experiences and then utilizing that bench‐derived knowledge in the practice of transfusion medicine.</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn2"><p>In addition to NBF seed grant, this work was also supported in part through NIH grants RO1HL092437, RO1HL092437‐A1S1, PO1HL095489, and PO1DK080665.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis</title></titleInfo><titleInfo type="abbreviated"><title>TRANSCRIPTION FACTORS IN HEMATOPOIESIS</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis</title></titleInfo><name type="personal"><namePart type="given">Li</namePart><namePart type="family">Chai</namePart><affiliation>From the Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</affiliation><description>Correspondence: L. Chai, Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115; e‐mail: .</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Blackwell Publishing Inc</publisher><place><placeTerm type="text">Malden, USA</placeTerm></place><dateIssued encoding="w3cdtf">2011-11</dateIssued><edition>Received for publication April 16, 2011; revision received June 17, 2011, and accepted June 30, 2011.</edition><copyrightDate encoding="w3cdtf">2011</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">5</extent><extent unit="tables">1</extent><extent unit="references">38</extent><extent unit="words">4393</extent></physicalDescription><abstract lang="en">The National Blood Foundation (NBF) support was critical in the author's research career development. The NBF support came in the form of a start‐up seed grant that she got from the American Association of Blood Banks, an organization that advances the practice and standards of transfusion medicine and cellular therapies and an organization in which she is a proud member. The NBF grant enabled her to keep up with her transfusion medicine practice while pursuing her passion to be a physician scientist. During its funding period, she was able to obtain critical preliminary bench data and to secure several National Institutes of Health grants with over a million dollars direct cost. In addition, the knowledge gained from the NBF‐supported projects is currently being translated into medical practice in her lab by testing on cord blood expansion. She is looking forward to spending the upcoming years of her professional career bridging bedside observations on transfusion medicine with bench experiences and then utilizing that bench‐derived knowledge in the practice of transfusion medicine.</abstract><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><genre type="Journal">journal</genre><identifier type="ISSN">0041-1132</identifier><identifier type="eISSN">1537-2995</identifier><identifier type="DOI">10.1111/(ISSN)1537-2995</identifier><identifier type="PublisherID">TRF</identifier><part><date>2011</date><detail type="title"><title>The National Blood Foundation: 10 Years of Supporting Pioneering Cellular Therapy Research</title></detail><detail type="volume"><caption>vol.</caption><number>51</number></detail><detail type="supplement"><caption>Suppl. no.</caption><number>s4</number></detail><extent unit="pages"><start>87S</start><end>93S</end><total>7</total></extent></part></relatedItem><identifier type="istex">ECEA792C6DB2ECF82EF69BEE4DD911D30F6B7EB0</identifier><identifier type="DOI">10.1111/j.1537-2995.2011.03371.x</identifier><identifier type="ArticleID">TRF3371</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2011 American Association of Blood Banks</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Publishing Inc</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/SchutzV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000899 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000899 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Musique
|area= SchutzV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:ECEA792C6DB2ECF82EF69BEE4DD911D30F6B7EB0
|texte= The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis
}}
| This area was generated with Dilib version V0.6.38. |  |